Table 1.
Characteristics of the vaccinated SARS-CoV-2 cohorts
| SARS-CoV-2 naive | SARS-CoV-2 previously infected | ||
|---|---|---|---|
| Number | 20 | 11 | |
| Age | 52 (33–64) | 48 (39–65) | |
| Gender | male (n) | 8 | 8 |
| female (n) | 12 | 3 | |
| Days between symptom onset and the first dosea | N/A | 300 (247–321) | |
| Days between the first and second dosesa | 111 (76–120) | 110 (90–134) | |
| Days between the second and third dosesa | 219 (167–230) | 219 (187–235) | |
| Days between the second dose and V3a | 21 (17–34) | 22 (13–42) | |
| Days between the second dose and V4 a | 112 (96–156) | 113 (90–127) | |
| Days between the third dose and V5a | 27 (20–38) | 27 (19–37) | |
| Days between the third dose and V6a | 119 (113–131) | 117 (111–127) | |
a
Values displayed are medians, with ranges in parentheses.